Epstein Secrets

business today to amend our Credit Agreement, including a reduction of the term loan by $75 million and expansion of our total leverage covenant." Buckelew continued, "We believe that this potential 12% reduction in our term loan and renegotiation of our total leverage covenant will be important proof

rst lien term loans outstanding under the First Lien Credit Agreement and $180.0 million of senior secured second lien term loans outstanding under the Second Lien Credit Agreement. In addition the Company has access to a $101.3 million first lien revolving loan facility, which as of December 31, 2013 was undrawn. " Procee

business today to amend our Credit Agreement including a reduction of the term loan by $75 million and expansion of our total leverage covenant." Buckelew continued, "We believe that this potential 12% reduction in our term loan and renegotiation of our total leverage covenant will be important proof

rst lien term loans outstanding under the First Lien Credit Agreement and $180.0 million of senior secured second lien term loans outstanding under the Second Lien Credit Agreement. In addition, the Company has access to a $101.3 million first lien revolving loan facility, which as of December 31, 2013 was undrawn. " Proce

business today to amend our Credit Agreement, including a reduction of the term loan by $75 million and expansion of our total leverage covenant." Buckelew continued, "We believe that this potential 12% reduction in our term loan and renegotiation of our total leverage covenant will be important proof p

rst lien term loans outstanding under the First Lien Credit Agreement and $180.0 million of senior secured second lien term loans outstanding under the Second Lien Credit Agreement. In addition the Company has access to a $101.3 million first lien revolving loan facility, which as of December 31, 2013 was undrawn. " Procee